Literature DB >> 25678454

Transfusion-Related Acute Lung Injury After IVIG for Myasthenic Crisis.

Dereddi Raja S Reddy1, Pramod K Guru, Melissa M Blessing, James R Stubbs, Alejandro A Rabinstein, Eelco F M Wijdicks.   

Abstract

BACKGROUND: A 26-year-old female with myasthenic crisis developed transfusion-related acute lung injury (TRALI) after she was treated with intravenous immunoglobulin.
METHODS: Case report.
RESULTS: Respiratory status markedly worsened with each intravenous immunoglobulin (IVIG) administration and progressing from a need to use bilevel positive airway pressure (BiPAP) to intubation. Pulmonary function tests improved during this episode.
CONCLUSIONS: IVIG may cause TRALI and due to subtle clinical findings can be mistaken for neuromuscular respiratory failure.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25678454     DOI: 10.1007/s12028-015-0115-z

Source DB:  PubMed          Journal:  Neurocrit Care        ISSN: 1541-6933            Impact factor:   3.210


  8 in total

1.  Transfusion-related acute lung injury after the infusion of IVIG.

Authors:  A Rizk; K C Gorson; L Kenney; R Weinstein
Journal:  Transfusion       Date:  2001-02       Impact factor: 3.157

2.  Tako-tsubo cardiomyopathy in a patient with myasthenia gravis crisis: a rare clinical association.

Authors:  Sasidharan Bijulal; Sivadasanpillai Harikrishnan; Narayanan Namboodiri; Valaparambil K Ajitkumar; Deepak Gupta; P S Mathuranath
Journal:  BMJ Case Rep       Date:  2009-02-16

Review 3.  Transfusion reactions: newer concepts on the pathophysiology, incidence, treatment, and prevention of transfusion-related acute lung injury.

Authors:  David M Sayah; Mark R Looney; Pearl Toy
Journal:  Crit Care Clin       Date:  2012-07       Impact factor: 3.598

4.  Transfusion-related acute lung injury following intravenous anti-D administration in an adolescent.

Authors:  Sivan Berger-Achituv; Martin H Ellis; Brian R Curtis; Baruch Wolach
Journal:  Am J Hematol       Date:  2008-08       Impact factor: 10.047

Review 5.  Potential links between neurological disease and Tako-Tsubo cardiomyopathy: a literature review.

Authors:  Francesco Santoro; Elena Carapelle; Sofia Isabel Cieza Ortiz; Francesco Musaico; Armando Ferraretti; Giuseppe d'Orsi; Luigi Maria Specchio; Matteo Di Biase; Natale Daniele Brunetti
Journal:  Int J Cardiol       Date:  2013-04-19       Impact factor: 4.164

6.  Transfusion-related acute lung injury after intravenous immunoglobulin treatment in a lung transplant recipient.

Authors:  A Stoclin; F Delbos; G Dauriat; O Brugière; N Boeri; A C Métivier; G Thabut; P Camus; H Mal
Journal:  Vox Sang       Date:  2012-09-18       Impact factor: 2.144

Review 7.  Transfusion-related acute lung injury: a clinical review.

Authors:  Alexander P J Vlaar; Nicole P Juffermans
Journal:  Lancet       Date:  2013-05-01       Impact factor: 79.321

8.  Emotional stress as a trigger of myasthenic crisis and concomitant takotsubo cardiomyopathy: a case report.

Authors:  Said R Beydoun; Jingtian Wang; Reed Loring Levine; Ali Farvid
Journal:  J Med Case Rep       Date:  2010-12-03
  8 in total
  5 in total

Review 1.  Pathogenesis and mechanisms of antibody-mediated hemolysis.

Authors:  Willy A Flegel
Journal:  Transfusion       Date:  2015-07       Impact factor: 3.157

Review 2.  HLA Class Ia and Ib Polyreactive Anti-HLA-E IgG2a Monoclonal Antibodies (TFL-006 and TFL-007) Suppress Anti-HLA IgG Production by CD19+ B Cells and Proliferation of CD4+ T Cells While Upregulating Tregs.

Authors:  Mepur H Ravindranath
Journal:  J Immunol Res       Date:  2017-05-28       Impact factor: 4.818

Review 3.  Adverse Effects of Immunoglobulin Therapy.

Authors:  Yi Guo; Xin Tian; Xuefeng Wang; Zheng Xiao
Journal:  Front Immunol       Date:  2018-06-08       Impact factor: 7.561

4.  Transfusion-related acute lung injury associated to intravenous immunoglobulin infusion in a pediatric patient.

Authors:  José Roberto Mendes Pegler; Ana Paula Beltran Moschione Castro; Antonio Carlos Pastorino; Mayra de Barros Dorna
Journal:  Einstein (Sao Paulo)       Date:  2020-12-07

Review 5.  Immunomodulatory therapy for the management of severe COVID-19. Beyond the anti-viral therapy: A comprehensive review.

Authors:  Jaume Alijotas-Reig; Enrique Esteve-Valverde; Cristina Belizna; Albert Selva-O'Callaghan; Josep Pardos-Gea; Angela Quintana; Arsene Mekinian; Ariadna Anunciacion-Llunell; Francesc Miró-Mur
Journal:  Autoimmun Rev       Date:  2020-05-03       Impact factor: 9.754

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.